Atrás
Rango del Día
$212.60
$219.18
Rango de 52 Semanas
$124.06
$248.60
Volumen
253,600
Promedio 50D / 200D
$225.73
/
$202.09
Cierre Anterior
$218.06
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -60.4 | 0.3 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | -31.7 | 3.8 |
| Rev Growth 5Y % | 207.1 | 10.0 |
| D/E | — | 0.2 |
Precio Objetivo de Analistas
Hold
$287.17
+33.2%
Low: $250.00
High: $342.00
P/E Futuro
51.7
EPS Futuro
$4.22
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
1.4 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$23.00
$19.34 – $26.46
|
3.4 B | 5 |
| FY2029 |
$20.07
$16.87 – $23.08
|
3.1 B | 2 |
| FY2028 |
$15.87
$10.83 – $21.46
|
2.5 B | 7 |
Puntos Clave
Revenue grew 207.09% annually over 5 years — strong growth
Generating 43.62M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 116.87%
Capital efficient — spends only 1.18% of revenue on capex
Crecimiento
Revenue Growth (5Y)
207.09%
Revenue (1Y)90.22%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
N/A
ROIC-13.85%
Net Margin-31.67%
Op. Margin-18.92%
Seguridad
Debt / Equity
N/A
Current Ratio1.04
Interest Coverage-1.69
Valoración
P/E Ratio
-60.40
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 90.22% | Revenue Growth (3Y) | 61.04% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 207.09% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 691.71M | Net Income (TTM) | -219.03M |
| ROE | N/A | ROA | -16.82% |
| Gross Margin | 85.08% | Operating Margin | -18.92% |
| Net Margin | -31.67% | Free Cash Flow (TTM) | 43.62M |
| ROIC | -13.85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.04 |
| Interest Coverage | -1.69 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -60.40 | P/B Ratio | N/A |
| P/S Ratio | 19.13 | PEG Ratio | 1.13 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 13.23B | Enterprise Value | 13.49B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 691.71M | 363.64M | 266.72M | 51.17M | 7.78M |
| Net Income | -219.03M | -378.08M | -481.45M | -583.19M | -383.58M |
| EPS (Diluted) | -3.62 | -6.53 | -8.55 | -10.40 | -7.00 |
| Gross Profit | 588.53M | 319.38M | 222.32M | 39.04M | 4.26M |
| Operating Income | -130.89M | -278.76M | -455.54M | -561.81M | -451.79M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.30B | 1.18B | 825.59M | 1.09B | 1.08B |
| Total Liabilities | 1.46B | 1.29B | 971.28M | 826.39M | 201.29M |
| Shareholders' Equity | -162.75M | -105.71M | -145.70M | 263.35M | 883.64M |
| Total Debt | 871.41M | 856.62M | 743.06M | 617.57M | 209.92M |
| Cash & Equivalents | 615.78M | 559.54M | 392.16M | 444.77M | 446.27M |
| Current Assets | 1.11B | 1.06B | 702.72M | 923.47M | 805.89M |
| Current Liabilities | 1.07B | 907.86M | 736.51M | 716.78M | 100.36M |